$TLPH Balance Sheet | Understand Stock

$TLPH

$1.09 +$0.02 (1.87%) Close

$TLPH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current Assets:
Cash and cash equivalents
Restricted cash
Short-term investments
Accounts receivable, net
Inventories, net
Prepaid expenses and other current assets
Assets of discontinued operations
Total current assets
Operating lease right-of-use assets
Property and equipment, net
In-process research and development asset
Other assets
Restricted cash, net of current portion
Total assets

Current Liabilities:
Accounts payable
Accrued and other liabilities
Long-term debt, current portion
Operating lease liabilities, current portion
Liabilities of discontinued operations
Total current liabilities
Long-term debt, net of current portion
Deferred revenue, net of current portion
Operating lease liabilities, net of current portion
Warrant liability
Liability related to the sale of future royalties
Other long-term liabilities
Liability related to the sale of future payments
Total liabilities
Series A Redeemable Convertible Preferred Stock, $0.001 par value—10,000,000 shares authorized, 3,000 and 0 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively, with a liquidation preference of $330,000

Stockholders’ Equity:
Common stock, $0.001 par value—200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 51,905,796 and 49,328,097 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total Liabilities and Stockholders’ Equity

Comments